Atlas Trials

Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)

Clinical trial NCT00167518 · COMPLETED

Trial details

NCT number
NCT00167518
Sponsor
University of Sydney
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Diabetic Macular Oedema
Start date
2002-03-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.